DRUG · Mapped RxNorm record
Sacituzumab Govitecan-hziy
Normalized identity: sacituzumab govitecan-hziyView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Study of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors
NCT05101096
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedStudy of Sacituzumab Govitecan (SG) in Japanese Participants With Advanced Solid Tumors
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE1, PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Advanced Solid Tumorunresolved
Metastatic Triple-Negative Breast Cancerunresolved
HR+/HER2- Metastatic Breast Cancerunresolved
Metastatic Urothelial Cancerunresolved
Interventions
Sacituzumab Govitecan-hziyDRUG · verified · RxNorm: sacituzumab govitecan-hziy
Sponsors & collaborators
Gilead Scienceslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05101096 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.